Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-12-1
|
pubmed:abstractText |
Using MG-63 cells as a model system capable of partial osteoblastic differentiation, we have examined the effect of growth on extracellular matrix. MG-63 cell matrix and purified type I collagen induced a morphological change characterized by long cytoplasmic processes reminiscent of those seen in osteocytes. Concurrent biochemical changes involving bone marker proteins included increased specific activity of cell-associated alkaline phosphatase and increased secretion of osteonectin (up to 2.5-fold for each protein); all changes occurred without alterations in the growth kinetics of the MG-63 cells. The increase in alkaline phosphatase activity was maximal on days 6-8 following seeding; increased osteonectin secretion was most prominent immediately following seeding; all changes decreased as cells reached confluence. Growing cells on type I collagen resulted in an increased induction of alkaline phosphatase activity by 1,25(OH)2D3 (with little change in the 1,25(OH)2D3 induction of osteonectin and osteocalcin secretion), and increased TGF-beta induction of alkaline phosphatase activity as well (both TGF-beta 1 and TGF-beta 2). Both the 1,25(OH)2D3 and TGF-beta effects appeared to be synergistic with growth on type I collagen. These studies support the hypothesis that bone extracellular matrix may play an important role in osteoblastic differentiation and phenotypic expression.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Calcitriol,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Osteonectin,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-9541
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
256-65
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1429847-Alkaline Phosphatase,
pubmed-meshheading:1429847-Animals,
pubmed-meshheading:1429847-Bone and Bones,
pubmed-meshheading:1429847-Calcitriol,
pubmed-meshheading:1429847-Cell Division,
pubmed-meshheading:1429847-Collagen,
pubmed-meshheading:1429847-Humans,
pubmed-meshheading:1429847-Osteoblasts,
pubmed-meshheading:1429847-Osteonectin,
pubmed-meshheading:1429847-Osteosarcoma,
pubmed-meshheading:1429847-Phenotype,
pubmed-meshheading:1429847-Rats,
pubmed-meshheading:1429847-Species Specificity,
pubmed-meshheading:1429847-Substrate Specificity,
pubmed-meshheading:1429847-Time Factors,
pubmed-meshheading:1429847-Transforming Growth Factor beta,
pubmed-meshheading:1429847-Tumor Cells, Cultured
|
pubmed:year |
1992
|
pubmed:articleTitle |
Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells.
|
pubmed:affiliation |
Department of Biochemistry, University of Vermont, Burlington 05405.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|